Immunic AG clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   ENSURE-1 · IMU-838 · Relapsing Multiple Sclerosis

   Trial sites expanded: 91 → 103 locations

   Immunic AG·Phase 3· NCT05134441· Registry history of NCT05134441 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

2. Minor

   ENSURE-2 · IMU-838 · Relapsing Multiple Sclerosis

   Trial sites expanded: 76 → 101 locations

   Immunic AG·Phase 3· NCT05201638· Registry history of NCT05201638 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.